PCSK9 inhibitors
What are PCSK9 inhibitors?
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an enzyme that binds to low-density lipoprotein receptors (LDL receptors), which stops LDL being removed from the blood, leading to an increase in blood levels of LDL. The PCSK9 inhibitor blocks the PCSK9 enzyme, resulting in more LDL receptors available to remove LDL from the blood, which produces in a decrease in LDL blood levels.
List of PCSK9 inhibitors
View by Generic | Brand
| Drug Name | Avg. Rating | Reviews |
|---|---|---|
| Repatha (Pro) Generic name: evolocumab |
714 reviews | |
| Praluent (Pro) Generic name: alirocumab |
306 reviews | |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
See also
Medical conditions treated or associated with PCSK9 inhibitors:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.